changing epigenetic markers in cll patients on ibrutinib
Published 7 years ago • 392 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
1:35
shifting the focus in cll: the epigenome
-
3:49
what does epigenetics mean to cll?
-
1:52
epigenetic features in cll - dna methylation
-
5:24
translating epigenetic therapy to the clinic: rational combinations
-
24:49
cell-free dna methylation analysis for cancer detection (chinese language)
-
12:50
introduction to epigenetics - learn.omicslogic.com
-
4:14
epigenetic modifications & epigenomic technologies
-
5:21
examples of biology informing treatment decisions in cll
-
2:48
epigenetic profiling and machine learning for risk stratification in pediatric all
-
2:37
next steps for genetic testing in cll
-
3:55
the molecular mechanisms of epigenetic therapies: ltrs and tinats
-
0:36
the use of ai for analyzing genetic and molecular data in cll
-
2:29
the measurement of molecular biomarkers to aid cll treatment
-
3:01
cell-intrinsic biomarkers in cll: focus on cytogenetics
-
1:45
the consequences of epigenetic drugs in the treatment of aml
-
3:19
from epigenetic mechanisms to cancer therapeutics
-
1:36
using genomics to predict cll progression
-
3:15
should standard chemotherapy regimens be altered in favor of small molecules? ifcg for frontline cll
-
4:17
altered pathways as a biomarker for disease outcomes in cll
-
1:53
classifying mpns with molecular genetic markers
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis